These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4323527)

  • 1. [Preparation and testing of an anti-aphthous vaccine with A22 virus cultured in tissue cultures].
    Orlov SD; Bykov IA; Ratner LS; Moutouzkina ZP; Ignatieva VS
    Bull Off Int Epizoot; 1969; 71(3-4):393-5. PubMed ID: 4323527
    [No Abstract]   [Full Text] [Related]  

  • 2. Basis of the preparation of A22 type foot-and-mouth disease vaccine in Turkey.
    Okay G; Sutcu M; Bayramoglu O; Oral M; Unluleblebici N; Senturk M; Girard HC
    Bull Off Int Epizoot; 1969; 71(3-4):341-50. PubMed ID: 4323524
    [No Abstract]   [Full Text] [Related]  

  • 3. [The problem of the relations between the test of protection in cattle and the index of protection in mice in the checking of the effectiveness of anti-aphthous vaccines prepared with cultured virus].
    Bengelsdorff HJ; Schneider B; Ackermann D
    Bull Off Int Epizoot; 1969; 71(3-4):405-17. PubMed ID: 4323529
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multiplication of the aphthous fever virus, variant A 22, in explants of lingual epithelium of cattle with prior aphthous fever].
    Skorine IE; Lebedev AI; Avilov VS; Bykov IA; Revenkov AG
    Bull Off Int Epizoot; 1969; 71(1-2):63-5. PubMed ID: 4315030
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cultivation of foot-and-mouth disease virus type O in tissue cultures and utilization of its mutability for the production of new vaccine strains].
    Mitev G; Tekerlekov P
    Arch Exp Veterinarmed; 1966 Mar; 20(1):91-7. PubMed ID: 4293437
    [No Abstract]   [Full Text] [Related]  

  • 6. Foot-and-mouth disease vaccine: influence of the vaccine virus subtype on neutralizing antibody and resistance to disease.
    Graves JH; McKercher PD; Callis JJ
    Am J Vet Res; 1972 Apr; 33(4):765-8. PubMed ID: 4336082
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the suitability of tissue culture neutralization tests in the government etesting of adsorbed foot-and mouth disease vaccines. 1. The content of neutralizing antibody in the serum of cattle after vaccination with adsorbed vaccine against type O2 virus in comparison with the direct immunity testing in cattle].
    Rüting E; Seils H; Weyhe D; Benndorf E
    Arch Exp Veterinarmed; 1969; 23(4):827-38. PubMed ID: 4319494
    [No Abstract]   [Full Text] [Related]  

  • 8. [New developments in the Frenkel method. Results obtained].
    Durand M; Giraud M; Guerche J; Berson JP; Prunet P
    Bull Off Int Epizoot; 1969; 71(3-4):263-83. PubMed ID: 4323521
    [No Abstract]   [Full Text] [Related]  

  • 9. [Duration of immunity after the use of anti-aphthous vaccine prepared with 10 and 25 milligrams of saponin per dose].
    Bayramoglu O; Unluleblebici N; Girard HC
    Bull Acad Vet Fr; 1968 Apr; 41(4):165-8. PubMed ID: 4314657
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological variability in the type of aphthous virus, its limits and practical significance].
    Muntiu N; Dohotaru V; Bercan A; Tomescu A
    Bull Off Int Epizoot; 1969; 71(3-4):249-61. PubMed ID: 4323520
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of anti-foot-and-mouth disease vaccine in oil adjuvant in young cattle].
    Brun A; Chappuis G; Favre H; Roulet C; Terré J
    Dev Biol Stand; 1976; 35():117-22. PubMed ID: 198277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological studies with cell cultured aluminium hydroxide gel adsorbed formalin inactivated foot and mouth disease type Asia I monovalent vaccine.
    Negi BS; Kumar S
    Indian Vet J; 1970 Jul; 47(7):555-61. PubMed ID: 4318813
    [No Abstract]   [Full Text] [Related]  

  • 13. [Post-vaccinal immunity against heterologous subtypes of the foot-and-mouth disease virus].
    Sobko AI; Sokolov LN; Mishchenko VA; Maslova NS; Dudnikov AI
    Veterinariia; 1977 Sep; (9):42-4. PubMed ID: 202059
    [No Abstract]   [Full Text] [Related]  

  • 14. Foot-and-mouth disease: a vaccine study.
    McKercher PD; Callis JJ
    Dev Biol Stand; 1976; 35():123-33. PubMed ID: 198278
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the production of monovalent foot-and-mouth disease vaccine concentrate from tissue culture virus type O].
    Mitev G; Wassilewa L; Tekerlekov P
    Arch Exp Veterinarmed; 1966 Mar; 20(1):85-90. PubMed ID: 4293436
    [No Abstract]   [Full Text] [Related]  

  • 16. [Foot-and-mouth virus component responsible for immunogenesis].
    Salazhov EL; Ivanov VS
    Veterinariia; 1970 Sep; 9():38-40. PubMed ID: 4323895
    [No Abstract]   [Full Text] [Related]  

  • 17. [Verification of a method of standardization of the antigens of anti-aphthous vaccine based on complement fixation capacity].
    Strobbe R; Debecq J; Leunen J
    Bull Off Int Epizoot; 1969; 71(3-4):397-404. PubMed ID: 4323528
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of alkylating agents for the inactivation of foot-and-mouth disease virus and the preparation of a new inactivated vaccine].
    Durand M; Guilloteau B; Giraud M; Guerche M; Pesson M; Prunet P
    Bull Off Int Epizoot; 1968; 69(3):429-65. PubMed ID: 4303692
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological study of the sub-types of aphthous virus. Principle; method; use].
    Lucam F; Dannacher G; Thomas JP; Magallanes N; Giambruno E; Marin J; Federer K; Alonso A
    Bull Off Int Epizoot; 1971; 75(1):1-20. PubMed ID: 4326913
    [No Abstract]   [Full Text] [Related]  

  • 20. Escape mutants of foot-and-mouth disease virus selected by monoclonal antibodies directed to a trypsin-sensitive neutralization epitope.
    Das BR; Pattnaik B; Venkataramanan R; Rai DV
    Acta Virol; 1997 Jun; 41(3):131-8. PubMed ID: 9385400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.